Literature DB >> 20055699

GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies.

Joël Bockaert1, Julie Perroy, Carine Bécamel, Philippe Marin, Laurent Fagni.   

Abstract

G protein-coupled receptors (GPCRs) are key transmembrane recognition molecules for regulatory signals such as light, odors, taste hormones, and neurotransmitters. In addition to activating guanine nucleotide binding proteins (G proteins), GPCRs associate with a variety of GPCR-interacting proteins (GIPs). GIPs contain structural interacting domains that allow the formation of large functional complexes involved in G protein-dependent and -independent signaling. At the cellular level, other functions of GIPs include targeting of GPCRs to subcellular compartments and their trafficking to and from the plasma membrane. Recently, roles of GPCR-GIP interactions in central nervous system physiology and pathologies have been revealed. Here, we highlight the role of GIPs in some important neurological and psychiatric disorders, as well as their potential for the future development of therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055699     DOI: 10.1146/annurev.pharmtox.010909.105705

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  61 in total

1.  The scaffold protein NHERF2 determines the coupling of P2Y1 nucleotide and mGluR5 glutamate receptor to different ion channels in neurons.

Authors:  Alexander K Filippov; Joseph Simon; Eric A Barnard; David A Brown
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

2.  Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala.

Authors:  Marc A Beckerman; Michael J Glass
Journal:  Exp Neurol       Date:  2010-10-21       Impact factor: 5.330

3.  RanBPM protein acts as a negative regulator of BLT2 receptor to attenuate BLT2-mediated cell motility.

Authors:  Jun-Dong Wei; Joo-Young Kim; Ae-Kyoung Kim; Sung Key Jang; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

Review 4.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

5.  Three Mutations in the Bilateral Frontoparietal Polymicrogyria Gene GPR56 in Pakistani Intellectual Disability Families.

Authors:  Humaira Aziz Sawal; Ricardo Harripaul; Anna Mikhailov; Kayla Vleuten; Farooq Naeem; Tanveer Nasr; Muhammad Jawad Hassan; John B Vincent; Muhammad Ayub; Muhammad Arshad Rafiq
Journal:  J Pediatr Genet       Date:  2017-12-21

6.  Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats.

Authors:  Saloua Benmansour; Opeyemi S Adeniji; Anthony A Privratsky; Alan Frazer
Journal:  Neuroendocrinology       Date:  2015-07-01       Impact factor: 4.914

Review 7.  Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.

Authors:  Ana C Magalhaes; Henry Dunn; Stephen Sg Ferguson
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 8.  G protein-coupled receptors: mutations and endocrine diseases.

Authors:  Gilbert Vassart; Sabine Costagliola
Journal:  Nat Rev Endocrinol       Date:  2011-02-08       Impact factor: 43.330

9.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

10.  Regulation of metabotropic glutamate receptor 7 (mGluR7) internalization and surface expression by Ser/Thr protein phosphatase 1.

Authors:  Young Ho Suh; Ji-Young Park; Sangwook Park; Ilo Jou; Paul A Roche; Katherine W Roche
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.